| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $169.1M | +504.8% |
| Cost of Revenue | $15.3M | +1705.8% |
| Gross Profit | $153.8M | +467.3% |
| R&D Expense | $15.2M | +14.6% |
| SG&A Expense | $181.0M | +19.3% |
| Operating Income | -$42.4M | +69.2% |
| Interest Expense | $10.8M | +9.5% |
| Pre-tax Income | -$49.1M | +69.5% |
| Income Tax | -$247K | +50.7% |
| Net Income | -$48.8M | +69.5% |
| EPS (Basic) | -$0.51 | +74.5% |
| EPS (Diluted) | -$0.51 | +74.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.4M | +64.8% |
| Short-term Investments | $22.4M | -69.7% |
| Accounts Receivable | $34.1M | +181.7% |
| Inventory | $20.3M | +95.5% |
| Current Assets | $134.2M | +0.0% |
| Total Assets | $164.2M | -0.3% |
| Current Liabilities | $48.8M | +32.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.9M | +63.5% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $51.8M | +203.4% |
| Financing Cash Flow | $16.0M | -88.2% |
| Free Cash Flow | -$46.9M | +63.5% |
| Total Liabilities |
| $90.4M |
| +17.4% |
| Stockholders' Equity | $73.8M | -15.8% |